title: [Preliminary results of foldable intraocular lens implantation in children with cataract].
abstract: OBJECTIVE
  To evaluate the result of phacoemulsification and foldable intraocular lens implantation (IOL) through a small incision in children with cataract.
  
  
  METHODS
  Phacoemulsification with anterior vitrectomy and foldable IOL implantation in the capsular bag was performed in 37 eyes of 28 children aged 3 - 15 years (mean 7 years), including 27 eyes of congenital cataract and 10 eyes of traumatic cataract. The visual acuity, corneal curvature and possible complication were followed up for 10 months (range, 3 - 15 months).
  
  
  RESULTS
  The best corrected visual acuity (BCVA) of congenital cataract were all >/= 0.1, and 59.3% >/= 0.5. All the BCVA of cases with traumatic cataract >/= 0.3, and 80% >/= 0.5. The surgically induced astigmatism (SIA) was (1.18 +/- 0.65) D, (0.67 +/- 0.59) D and (0.60 +/- 0.39) D in one week, one month, and three months respectively after the operation, and it was stable in the postoperative one month. Secondary cataract occurred in 5 cases (13.5%), and no other complications were found.
  
  
  CONCLUSIONS
  Phacoemulsification and foldable IOL implantation through a small incision in children with cataract can reduce early post-operative astigmatism and shorten the period of visual rehabilitation. It is a safe procedure with milder inflammatory reaction and less complication.
authors.affiliation: Shandong Eye Institute & Hospital, Qingdao 266071, China.
authors.forename: Zhan
authors.initials: Z
authors.lastname: Yao
authors.forename: Lixin
authors.initials: L
authors.lastname: Xie
authors.forename: Yusen
authors.initials: Y
authors.lastname: Huang
authors.forename: Zhipeng
authors.initials: Z
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D001251:Astigmatism / Q000209:etiology; D002386:Cataract / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000009:adverse effects / Q000379:methods*; D008297:Male; D018918:Phacoemulsification / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome; D014792:Visual Acuity